OSR Health (OSRHW) Change in Receivables (2024 - 2026)
OSR Health (OSRHW) posted Change in Receivables of -$109121.7 for Q1 2026, little changed sequentially from -$109532.0 in Q4 2025, and up 21.81% YoY from -$89580.3 in Q1 2025.
OSR Health (OSRHW) Change in Receivables (2024 - 2026) Analysis & Trends
OSR Health has reported Change in Receivables for 3 years, with the latest figure at -$109121.7 in Q1 2026.
- Quarterly Change in Receivables rose 21.81% year-over-year to -$109121.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$540287.3 (down 154.54% YoY) and the FY2025 annual result came in at -$570733.0, down 550.15% from the prior year.
- Change in Receivables steadied at -$109121.7 in Q1 2026 per OSRHW's latest filing, from -$109532.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $66373.0 in Q4 2024 and troughed at -$210243.0 in Q3 2025.
- A 3-year average of -$85293.3 and a median of -$109532.0 in 2025 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2025 and 2026: Change in Receivables tumbled 824.96% in 2025, then increased 21.81% in 2026.
- Over 3 years, Change in Receivables stood at $66373.0 in 2024, then plunged by 265.02% to -$109532.0 in 2025, then advanced by 0.37% to -$109121.7 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$109121.7, -$109532.0, and -$210243.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | 37.16 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | -60,058.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109,121.67 |
| Mar 31, 2026 | -109,121.67 |
| Dec 31, 2025 | -109,532.00 |
| Dec 31, 2025 | -109,532.00 |
| Sep 30, 2025 | -210,243.00 |
| Sep 30, 2025 | -210,243.00 |
| Jun 30, 2025 | -111,390.62 |
| Jun 30, 2025 | -111,390.62 |
| Mar 31, 2025 | -139,567.38 |
| Mar 31, 2025 | -139,567.38 |
| Dec 31, 2024 | 66,373.00 |
| Dec 31, 2024 | 66,373.00 |
| Sep 30, 2024 | -124,451.00 |
| Sep 30, 2024 | -124,451.00 |
| Jun 30, 2024 | -14,618.00 |
| Jun 30, 2024 | -14,618.00 |
| Mar 31, 2024 | -15,089.00 |
| Mar 31, 2024 | -15,089.00 |